Guangzhou Fuda Cancer Hospital

This study integrates multiple diseases, breaking down their causes, symptoms, and key diagnostic and treatment points.

Hospital Overview

Guangzhou Fuda Cancer Hospital is a tertiary cancer specialty hospital directly under the Guangdong Provincial Health Commission. Established in 2003, the hospital focuses on the comprehensive treatment of mid-to-late stage malignant tumors, with particular strengths in minimally invasive tumor therapies, including cryoablation, irreversible electroporation (IRE), vascular intervention, and combined immunotherapy.

City

Two campuses located in Tianhe District and Haizhu District.

Hospital Positioning

A specialized hospital focusing on comprehensive diagnosis and treatment of malignant tumors.

Regional Medical

The hospital has treated international patients from more than 100 countries, with over 50% of inpatients coming from overseas regions.

2003

Established

33,000 m²

Building Area

400

Licensed Beds

VIP Patient Rooms

507

Staff Members

Core treatment areas

Core Specialties

The hospital adheres to the development path of “high-end, academic, and international” orientation, focusing on treating mid-to-late stage malignant tumors as the primary treatment targets. The hospital emphasizes the “3C+P” treatment model featuring Cryosurgery (CSA), Irreversible Electroporation (IRE), Cancer Vascular Intervention (CVI), Combined Immunotherapy (CIC), and Individualized Treatment (P).

Core Advantages

The hospital has treated nearly 10,000 tumor cases with cryoablation, ranking among the world leaders in the number and variety of tumor types treated. The hospital has achieved remarkable success in treating central lung cancer, giant liver cancer, and pancreatic cancer. The number of Nano-knife procedures ranks among the highest in Asia. The hospital has published 212 SCI papers, 160 Chinese core journal papers, and obtained 6 invention patents. The hospital attracts patients from over 100 countries including the United States, United Kingdom, Japan, Singapore, Canada, Thailand, Malaysia, and Indonesia, with over 50% of inpatients coming from Southeast Asia, Middle East, Africa, Europe, and North America.

Authoritative Qualifications & International Cooperation

International accreditation experience, national oncology qualifications, and international academic cooperation support specialized cancer care.

International Certifications

JCI International Accreditation

The hospital first received JCI international accreditation in 2014 and passed its re-survey in 2017 with a score of 9.91. According to the document, it was the first JCI-accredited cancer specialty hospital in Guangdong Province.

National Clinical Key Specialty – Oncology

Selected as a National Clinical Key Specialty in 2010 and passed the first verification in 2018. According to the document, it was the only national clinical key cancer specialty among more than 20,000 private medical institutions nationwide.

National Integrity Private Hospital

The hospital has received multiple recognitions as a National Integrity Private Hospital.

National Quality Demonstration Hospital

International Cooperation

International Cryotherapy Collaboration

International Society of Cryosurgery

Professor Xu Kecheng and Dr. Niu Lizhi were elected Executive Committee members of the International Society of Cryosurgery (ISC), and Professor Xu Kecheng was elected President of the ISC in 2013.

Specialty Centers & Core Medical Sciences

Specialized oncology centers integrate minimally invasive technologies, interventional treatment, immunotherapy, and individualized cancer care.

CRA

Tumor Cryoablation

IRE

Nano-knife Treatment

ITC

Tumor Interventional Treatment

Medical Oncology

Leading key specialties

CRA — Tumor Cryoablation Center

Department Overview

Fuda introduced cryotherapy from the United States in 2000. The cryotherapy team had completed more than 10,000 treatment cases by 2015, placing it among the leading centers described in the document.

Core Technologies

Cryosurgery Ablation
Uses rapid cooling and rewarming for tumor ablation.

Laparoscopic Cryoablation
Combines minimally invasive surgery with cryotherapy.

Percutaneous Cryoablation
CT- or ultrasound-guided percutaneous tumor ablation.

Deep Tumor Cryotherapy
Applied to tumors involving deep organs such as the liver, lung, and pancreas.

Intraoperative Cryotherapy
Cryotherapy performed during surgery to treat residual tumor tissue.

Argon-Helium Cryoablation
Controlled-temperature tumor ablation using argon-helium technology.

Areas of expertise:

Tumor cryoablation
Nano-knife treatment
Minimally invasive treatment of complex solid tumors

Leading key specialties

IRE — Nano-knife Treatment Center

Department Overview

The Nano-knife treatment team led by Dr. Niu Lizhi has completed more than 1,000 Nano-knife procedures. According to the document, its procedural volume ranks among the leading centers in Asia.

Core Technologies

Irreversible Electroporation (IRE)
Uses high-voltage electrical pulses to create irreversible pores in tumor cell membranes.

IRE Combined with Immunotherapy
Combines Nano-knife ablation with immunotherapy.

IRE for Tumors Near Critical Structures
Designed for tumors located near blood vessels, bile ducts, nerves, and other important structures.

IRE for Pancreatic Cancer
Nano-knife ablation applied in pancreatic cancer treatment.

IRE for Prostate Cancer
Precision ablation for prostate cancer.

Image-Guided IRE
CT- or ultrasound-guided tumor ablation.

Leading key specialties

ITC — Tumor Interventional Treatment Center

Department Overview

The Tumor Interventional Treatment Center is led by Professor Yang Qingfeng and Director Zhou Qiang. The team uses interventional techniques, including drug-carrying microspheres, to target tumor vasculature.

Core Technologies

Transarterial Chemoembolization (TACE)
Catheter-based arterial chemoembolization for liver cancer.

Drug-Eluting Bead Embolization
Drug-carrying microspheres provide localized embolization and drug delivery.

Tumor Angiography
Identifies tumor-feeding blood vessels for interventional treatment.

Microwave Ablation
Minimally invasive thermal ablation for solid tumors.

Radiofrequency Ablation
Minimally invasive treatment for liver, lung, and other tumors.

Radioactive Seed Implantation
Iodine-125 seed implantation for localized brachytherapy.

Leading key specialties

MO — Medical Oncology Department

Department Overview

The Medical Oncology Department combines standardized cancer treatment with minimally invasive therapies such as Nano-knife treatment, cryoablation, and vascular intervention, while incorporating precision medicine into comprehensive cancer care.

Core Technologies

Combined Immunotherapy (CIC)
Combines multiple immunotherapeutic approaches.

Ozone Blood Activation Therapy
Listed in the document as part of the department’s treatment technologies.

Targeted Therapy
Targeted treatment based on tumor-related molecular characteristics.

Photodynamic Therapy
Uses photosensitizing agents as part of treatment for selected tumors.

TCM Adjuvant Therapy
Integrates Traditional Chinese Medicine with other cancer treatments.

Palliative Care
Supportive treatment focused on quality of life.

Cutting-Edge Diagnostic & Treatment Technologies

Cryoablation is one of the hospital’s major minimally invasive cancer treatment technologies, with experience covering a variety of solid tumors.

Irreversible electroporation uses high-voltage electrical pulses to ablate tumor cells and is applied to selected tumors, including lesions located near important anatomical structures.

Interventional oncology techniques include TACE, drug-eluting bead embolization, tumor angiography, and other image-guided procedures.

Combined immunotherapy forms part of the hospital’s comprehensive oncology treatment model and can be integrated with other treatment approaches.

Modern Medical Facilities & International Patient Care

Specialized oncology equipment, comfortable inpatient facilities, and international patient services support comprehensive cancer treatment.

Hospital Environment

Hospital Exterior

Tianhe Campus Exterior

Guangzhou Fuda Cancer Hospital Building

Outpatient Reception Area

Hospital Public Space

High-end medical equipment

PET-CT

Advanced molecular imaging equipment supporting tumor detection, staging, treatment planning, and clinical evaluation.

3.0T MRI

High-field magnetic resonance imaging supporting detailed diagnostic assessment across multiple tumor types.

Cryoablation System

Specialized equipment supporting image-guided minimally invasive cryoablation of selected solid tumors.

Location and Transportation